Sarka Dvorakova

Sarka Dvorakova

Auto-generated profile, based on publicly available information

Sarka Dvorakova

Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2020 in Thyroid®
Verified
Journal Article
Closed access
BPBarbora Pekova
Barbora Pekova
VSVlasta Sykorova
Vlasta Sykorova
SDSarka Dvorakova
Sarka Dvorakova
EVEliska Vaclavikova
Eliska Vaclavikova
JMJitka Moravcova
Jitka Moravcova
BBBela Bendlova
Bela Bendlova
Background: Pediatric papillary thyroid carcinoma (PTC) is a rare malignancy, but with increasing incidence. Pediatric PTCs have distinct clinical and pathological features and even the molecular profile differs from adult PTCs. Somatic point mutations in pediatric PTCs have been previously described and studied, but complex information about fusion genes is lacking. The aim of this study was to identify different fusion genes in a large cohort of pediatric PTCs and to correlate them with clinical and pathological data of patients. Methods: The cohort consisted of 93 pediatric PTC patients (6–20 years old). DNA and RNA were extracted from fresh frozen tissue samples, followed by DNA and RNA-targeted next-generation sequencing analyses. Fusion gene-positive samples were verified by real-time polymerase chain reaction. Results: A genetic alteration was found in 72/93 (77.4%) pediatric PTC cases. In 52/93 (55.9%) pediatric PTC patients, a fusion gene was detected. Twenty different types of RET , NTRK3 , ALK , NTRK1 , BRAF , and MET fusions were found, of which five novel, TPR/RET , IKBKG/RET , BBIP1/RET , OPTN/BRAF , and EML4/MET , rearrangements were identified and a CUL1/BRAF rearrangement that has not been previously described in thyroid cancer. Fusion gene-positive PTCs were significantly associated with the mixture of classical and follicular variants of PTC, extrathyroidal extension, higher T classification, lymph node and distant metastases, chronic lymphocytic thyroiditis, and frequent occurrence of psammoma bodies compared with fusion gene-negative PTCs. Fusion-positive patients also received more doses of radioiodine therapy. The most common fusion genes were the RET fusions, followed by NTRK3 fusions. RET fusions were associated with more frequent lymph node and distant metastases and psammoma bodies, and NTRK3 fusions were associated with the follicular variant of PTC. Conclusions: Fusion genes were the most common genetic alterations in pediatric PTCs. Fusion gene-positive PTCs were associated with more aggressive disease than fusion gene-negative PTCs.

1 March 2008 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
SDS. Dvorakova
S. Dvorakova
EVE. Vaclavikova
E. Vaclavikova
VSV. Sykorova
V. Sykorova
JVJ. Vcelak
J. Vcelak
ZNZ. Novak
Z. Novak
BBB. Bendlova
B. Bendlova


1 January 2005 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
SDS. Dvorakova
S. Dvorakova
EVE. Vaclavikova
E. Vaclavikova
JDJaroslava Dušková
Jaroslava Dušková
PVP. Vlcek
P. Vlcek
ARAleš Ryška
Aleš Ryška
BBB. Bendlova
B. Bendlova

1 March 2006 in Thyroid®
Verified
Journal Article
Closed access
ŠDŠ. Dvořáková
Š. Dvořáková
EVE. Václavíková
E. Václavíková
VSV. Sýkorová
V. Sýkorová
JDJaroslava Dušková
Jaroslava Dušková
PVP. Vlček
P. Vlček
BBB. Bendlová
B. Bendlová
Medullary thyroid carcinoma (MTC) occurs mostly as a sporadic tumor or in connection with inherited cancer syndromes-multiple endocrine neoplasia (MEN) types 2A and 2B and familial MTC. Germline mutations in the RET proto-oncogene are found in most of the familial cases. Somatic mutations in the RET proto-oncogene are detected in 23%-69% of patients with sporadic MTC. The most frequent somatic mutation is Met918Thr in exon 16 and only a small percentage of mutations in other RET exons have been observed. In a very few cases double mutations were found. Genetic screening for somatic mutations in RET exons 10, 11, 13, 14, 15, and 16 in Czech patients with sporadic MTC was carried out by DNA sequencing. This study presents a new triplesomatic mutation Gly911Asp, Met918Thr, and Glu921Lys in exon 16 of the RET proto-oncogene detected in an 18-year-old Czech male patient. In the second case, a new double-somatic mutation Val591Ile in exon 10 with a concomitant somatic mutation Met918Thr in exon 16 was found in a 77-year-old Czech female patient. These both newly described somatic multiple mutations were revealed in a hemizygous status, the loss of heterozygosity in tumor tissues in comparison with germline DNA was confirmed.

1 June 2005 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
ŠDŠárka Dvořáková
Šárka Dvořáková
KDKateřina Dvořáková
Kateřina Dvořáková
MMMarcela Malíková
Marcela Malíková
RŠRichard Škába
Richard Škába
PVPetr Vlček
Petr Vlček
BBBěla Bendlová
Běla Bendlová